title: Effects of putative galanin antagonists M35 and C7 on rat exocrine pancreas.
abstract: Galanin is a neuropeptide having a wide range of biological actions. Recently selective galanin receptor antagonists such as M35 [galanin(1-12)-Pro-bradykinin(2-9)-amide] and C7 [galanin(1-12)-Pro-spantide-amide] have been described. These antagonists have blocked the actions of galanin on flexor reflex, glucose-induced insulin secretion, and acetyicholine release from hippocampus. Our present aim was to investigate whether M35 and C7 can affect galanin-induced inhibition of pancreatic enzyme secretion in rats. Pancreatic enzyme secretion was studied in urethane-anesthetized rats supplied with jugular vein catheter and pancreatic cannula. Amylase secretion evoked by submaximal CCK-8 stimulation was inhibited dose-dependently by galanin in anesthetized rats. Surprisingly, neither M35 nor C7 was able to inhibit the responses of the exocrine pancreas to galanin. However, both putative galanin receptor antagonists behaved as agonists in our experimental models. Our data suggest that the effects of galanin on pancreatic enzyme secretion are not mediated by M35- or C7-sensitive galanin receptors. Therefore, these galanin receptors are different from those described in the central nervous system.
authors.affiliation: Institute of Experimental Medicine, Hungarian Academy of Sciences, 1450 Budapest, PO Box 67, Hungary.
authors.forename: I
authors.initials: I
authors.lastname: Kisfalvi
authors.forename: G
authors.initials: G
authors.lastname: Rácz
authors.forename: A
authors.initials: A
authors.lastname: Bálint
authors.forename: M
authors.initials: M
authors.lastname: Máté
authors.forename: A
authors.initials: A
authors.lastname: Oláh
authors.forename: T
authors.initials: T
authors.lastname: Zelles
authors.forename: E S
authors.initials: ES
authors.lastname: Vizi
authors.forename: G
authors.initials: G
authors.lastname: Varga
mesh_terms: D000681:Amylases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000818:Animals; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D019004:Galanin / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D008297:Male; D010179:Pancreas / Q000187:drug effects* / Q000201:enzymology; D010446:Peptide Fragments / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012844:Sincalide / Q000494:pharmacology; D013373:Substance P / Q000031:analogs & derivatives / Q000494:pharmacology*
chemical_list: D004338:Drug Combinations; D010446:Peptide Fragments; C074069:galanin-(1-13)-bradykinin-(2-9)-amide; C079788:galanin (1-13)-spantide amide; D013373:Substance P; D019004:Galanin; D000681:Amylases; D012844:Sincalide; D001920:Bradykinin